Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryDermoscopy software that supports melanocytic and non-melanocytic lesion assessment with image comparison, AI score, heatmap, and expert second-opinion options.
Dermatology teams already using structured dermoscopy or FotoFinder imaging who want clinician-reviewed AI scoring and longitudinal lesion comparison.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating FotoFinder Moleanalyzer pro as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm device/software version, country, intended use, compatible FotoFinder hardware, and labeling before using AI score or heatmap outputs in clinical care. |
|---|---|
| Privacy | Review FotoFinder Hub account use, anonymized image transfer for online AI scoring, local offline options, ports, server access, image storage, consent, and data-protection terms. |
| Evidence | Validate on local dermoscopy images with supported magnification, artifacts, calibration quality, lesion types, biopsy outcomes, and clinician disagreement review. |
| Workflow | Best governed as dermatologist-supervised dermoscopy support with manual assessment, longitudinal comparison, second opinion when needed, and final diagnosis outside the AI score. |
FotoFinder describes Moleanalyzer pro as dermoscopy software for analysis, comparison, second opinion, and AI support; its instructions for use describe a CNN-based AI Score, online and offline scoring options, image-transfer requirements, and warnings that the AI Score is statistical support for doctors and not guaranteed.
Not for: Standalone melanoma diagnosis, replacing clinician assessment or biopsy, or using AI scores without supported magnification, calibration, image quality, and workflow controls.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.